Inhalational induction: A safe anaesthetic management in a patient with crouzon syndrome
, , , oraz
29 gru 2022
O artykule
Kategoria artykułu: Case-Report
Data publikacji: 29 gru 2022
Zakres stron: 61 - 62
DOI: https://doi.org/10.2478/rjaic-2021-0010
Słowa kluczowe
© 2021 Sudeep Mohapatra et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Crouzon syndrome is a rare genetic disorder involving craniofacial skeleton development. It’s characterized by a triad of cranial deformities: premature craniosynostosis, facial anomalies (mid-facial hypoplasia), and exophthalmia. The anaesthetic management challenges include the presence of a difficult airway, history of obstructive sleep apnea, congenital cardiac disorders, hypothermia, blood loss, and venous air embolism. We present the case of an infant with Crouzon syndrome who was scheduled for a ventriculoperitoneal shunt placement managed with inhalational induction.